ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a cash flow conversion efficiency ratio of 0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥288.83 Million ≈ $42.27 Million USD) by net assets (CN¥3.24 Billion ≈ $474.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600479 company net worth for the company's overall valuation and market capitalisation.
ZhuZhou QianJin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 600479 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pegavision
TW:6491
|
0.067x |
|
Yotrio Group Co Ltd
SHE:002489
|
-0.246x |
|
Upbound Group Inc.
NASDAQ:UPBD
|
0.168x |
|
Mega Lifesciences Public Company Limited
BK:MEGA
|
0.046x |
|
Malion New Materials Co Ltd
SHE:300586
|
0.008x |
|
Mcmillan Shakespeare Ltd
AU:MMS
|
-0.294x |
|
Tianjin Printronics Circuit Corp
SHE:002134
|
0.043x |
|
Bajaj Mobility AG
VI:BMAG
|
N/A |
Annual Cash Flow Conversion Efficiency for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. View ZhuZhou QianJin Pharmaceutical Co Ltd (600479) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.35 Billion ≈ $490.23 Million |
CN¥480.24 Million ≈ $70.27 Million |
0.143x | +12.85% |
| 2024-12-31 | CN¥3.14 Billion ≈ $459.36 Million |
CN¥398.77 Million ≈ $58.35 Million |
0.127x | -13.23% |
| 2023-12-31 | CN¥3.03 Billion ≈ $442.91 Million |
CN¥443.12 Million ≈ $64.84 Million |
0.146x | -44.02% |
| 2022-12-31 | CN¥2.80 Billion ≈ $410.37 Million |
CN¥733.47 Million ≈ $107.33 Million |
0.262x | +45.43% |
| 2021-12-31 | CN¥2.70 Billion ≈ $395.08 Million |
CN¥485.57 Million ≈ $71.05 Million |
0.180x | -8.41% |
| 2020-12-31 | CN¥2.76 Billion ≈ $404.17 Million |
CN¥542.37 Million ≈ $79.37 Million |
0.196x | +232.09% |
| 2019-12-31 | CN¥2.63 Billion ≈ $384.79 Million |
CN¥155.49 Million ≈ $22.75 Million |
0.059x | -62.53% |
| 2018-12-31 | CN¥2.43 Billion ≈ $355.58 Million |
CN¥383.47 Million ≈ $56.11 Million |
0.158x | +24.77% |
| 2017-12-31 | CN¥2.24 Billion ≈ $327.95 Million |
CN¥283.47 Million ≈ $41.48 Million |
0.126x | +87.09% |
| 2016-12-31 | CN¥2.08 Billion ≈ $304.94 Million |
CN¥140.88 Million ≈ $20.62 Million |
0.068x | +96.75% |
| 2015-12-31 | CN¥1.96 Billion ≈ $287.40 Million |
CN¥67.48 Million ≈ $9.88 Million |
0.034x | -74.03% |
| 2014-12-31 | CN¥1.39 Billion ≈ $202.78 Million |
CN¥183.34 Million ≈ $26.83 Million |
0.132x | +15.78% |
| 2013-12-31 | CN¥1.20 Billion ≈ $176.24 Million |
CN¥137.63 Million ≈ $20.14 Million |
0.114x | -38.53% |
| 2012-12-31 | CN¥1.06 Billion ≈ $155.70 Million |
CN¥197.82 Million ≈ $28.95 Million |
0.186x | +718.11% |
| 2011-12-31 | CN¥993.56 Million ≈ $145.39 Million |
CN¥22.58 Million ≈ $3.30 Million |
0.023x | -45.42% |
| 2010-12-31 | CN¥939.81 Million ≈ $137.52 Million |
CN¥39.13 Million ≈ $5.73 Million |
0.042x | -46.14% |
| 2009-12-31 | CN¥951.29 Million ≈ $139.20 Million |
CN¥73.54 Million ≈ $10.76 Million |
0.077x | +81.97% |
| 2008-12-31 | CN¥875.75 Million ≈ $128.15 Million |
CN¥37.20 Million ≈ $5.44 Million |
0.042x | -51.98% |
| 2007-12-31 | CN¥895.95 Million ≈ $131.11 Million |
CN¥79.26 Million ≈ $11.60 Million |
0.088x | -51.42% |
| 2006-12-31 | CN¥659.60 Million ≈ $96.52 Million |
CN¥120.12 Million ≈ $17.58 Million |
0.182x | +41.61% |
| 2005-12-31 | CN¥594.85 Million ≈ $87.05 Million |
CN¥76.50 Million ≈ $11.19 Million |
0.129x | +348.90% |
| 2004-12-31 | CN¥644.15 Million ≈ $94.26 Million |
CN¥18.45 Million ≈ $2.70 Million |
0.029x | -86.90% |
| 2003-12-31 | CN¥233.07 Million ≈ $34.10 Million |
CN¥50.96 Million ≈ $7.46 Million |
0.219x | +567.95% |
| 2002-12-31 | CN¥185.56 Million ≈ $27.15 Million |
CN¥6.07 Million ≈ $888.87K |
0.033x | -- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more